检索
AI 对话
AI 写作
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Preclinical development of M4112, an IDO1/TDO2 dual selective and orally bioavailable small molecule inhibitor, and combination with avelumab, for treatment of solid tumors

Jieqing Chen, Chia Lin Chu,Feng Jiang,Chunxiao Xu,Yanping Zhang,Sireesha Yalavarthi, Molly Coop, Hong Wang, Yanyan Wang,Bettina Hanschke,Anindya Siddharta,Sen Zhang,Amit Deshpande,Bartholomew Naughton, Filippos Porichis, Tai-An Lin,Joern-Peter Halle, Tilo Senger, Brian Sherer,Jacques Moisan

JOURNAL FOR IMMUNOTHERAPY OF CANCER（2019）

引用 0|浏览10
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要